1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. LUPIN LTD.

Lupin Ltd. NSE: LUPIN | BSE: 500257

Mid-range Performer

1991.85 23.40 (1.19%)

33.39% Gain from 52W Low

559.7K NSE+BSE Volume

NSE 17 Mar, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
US FDA Approval
Lupin gets US FDA tentative approval for Amifampridine tablets, with a market size of $306 million See details

Detailed Stock Analysis for Lupin Ltd. with Real-time Stock Report

crown icon
Premium Feature
Please subscribe to GuruQ or StratQ
Subscribe Sign in